• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eosinophilic pneumonia and esophagitis in a patient with malignant melanoma treated with nivolumab.

作者信息

Hattori Yuki, Matsuyama Kanako, Shu En, Seishima Mariko

机构信息

Department of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.

出版信息

J Dermatol. 2019 Dec;46(12):e454-e455. doi: 10.1111/1346-8138.15030. Epub 2019 Jul 29.

DOI:10.1111/1346-8138.15030
PMID:31353501
Abstract
摘要

相似文献

1
Eosinophilic pneumonia and esophagitis in a patient with malignant melanoma treated with nivolumab.
J Dermatol. 2019 Dec;46(12):e454-e455. doi: 10.1111/1346-8138.15030. Epub 2019 Jul 29.
2
Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.纳武单抗诱导的多发性硬斑病伴嗜酸性筋膜炎。
Eur J Dermatol. 2021 Dec 1;31(6):844-846. doi: 10.1684/ejd.2021.4181.
3
Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.与纳武单抗相关的转移性恶性黑色素瘤放射性回忆性皮炎
Int J Dermatol. 2017 Apr;56(4):e75-e77. doi: 10.1111/ijd.13513. Epub 2017 Jan 19.
4
Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.纳武单抗诱发晚期恶性黑色素瘤患者出现缓解性血清阴性对称性滑膜炎伴凹陷性水肿（RS3PE）综合征的病例
J Dermatol. 2017 Aug;44(8):e196-e197. doi: 10.1111/1346-8138.13840. Epub 2017 Apr 9.
5
Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.与纳武单抗治疗恶性黑色素瘤相关的硬皮病样综合征。
J Dermatol. 2019 Jan;46(1):e43-e44. doi: 10.1111/1346-8138.14492. Epub 2018 Jun 4.
6
Uncommon esophagitis associated with nivolumab and ipilimumab therapy.与纳武单抗和伊匹单抗治疗相关的罕见食管炎。
Dig Endosc. 2021 Mar;33(3):467-468. doi: 10.1111/den.13902. Epub 2020 Dec 29.
7
Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient.一名黑色素瘤患者中1型糖尿病与低剂量纳武利尤单抗治疗相关的病例。
J Dermatol. 2017 May;44(5):605-606. doi: 10.1111/1346-8138.13486. Epub 2016 Jun 23.
8
Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.一名转移性恶性黑色素瘤患者在使用纳武单抗治疗失败后，因使用伊匹单抗诱发大疱性类天疱疮。
J Dermatol. 2018 Jan;45(1):e21-e22. doi: 10.1111/1346-8138.14043. Epub 2017 Sep 25.
9
Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.纳武单抗诱发恶性黑色素瘤患者的结肠炎：一例病例报告及免疫分析
J Dermatol. 2019 Sep;46(9):e339-e341. doi: 10.1111/1346-8138.14857. Epub 2019 Mar 25.
10
Infusion reaction to nivolumab in a metastatic melanoma patient. Safe switch to another anti-programmed death-1: a case report.纳武利尤单抗治疗转移性黑色素瘤患者的输液反应。安全转换为另一种抗程序性死亡-1 药物：病例报告。
Melanoma Res. 2021 Feb 1;31(1):88-91. doi: 10.1097/CMR.0000000000000710.

引用本文的文献

1
Successful management of chronic eosinophilic pneumonia triggered by immune checkpoint inhibitor: a case report and literature review.免疫检查点抑制剂引发的慢性嗜酸性粒细胞性肺炎的成功管理：一例报告及文献综述
Front Immunol. 2025 Jul 22;16:1615531. doi: 10.3389/fimmu.2025.1615531. eCollection 2025.
2
Causes of death among patients with cutaneous melanoma: a US population-based study.美国人群中皮肤黑色素瘤患者的死因分析：一项基于人群的研究。
Sci Rep. 2023 Jun 24;13(1):10257. doi: 10.1038/s41598-023-37333-4.
3
Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies.
病例报告：美泊利珠单抗成功用于治疗两名实体恶性肿瘤患者因免疫检查点抑制剂引起的嗜酸性粒细胞增多综合征。
Front Oncol. 2023 Jan 26;13:1079034. doi: 10.3389/fonc.2023.1079034. eCollection 2023.
4
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer.与免疫检查点抑制剂使用相关的肺部毒性：癌症支持治疗多国协会中性粒细胞减少、感染与骨髓抑制研究组免疫肿瘤学亚组的最新进展
Front Pharmacol. 2021 Oct 5;12:743582. doi: 10.3389/fphar.2021.743582. eCollection 2021.